276 related articles for article (PubMed ID: 21429763)
1. Antivenoms for the treatment of snakebite envenomings: the road ahead.
Gutiérrez JM; León G; Burnouf T
Biologicals; 2011 May; 39(3):129-42. PubMed ID: 21429763
[TBL] [Abstract][Full Text] [Related]
2. Innovative Immunization Strategies for Antivenom Development.
Bermúdez-Méndez E; Fuglsang-Madsen A; Føns S; Lomonte B; Gutiérrez JM; Laustsen AH
Toxins (Basel); 2018 Nov; 10(11):. PubMed ID: 30400220
[TBL] [Abstract][Full Text] [Related]
3. Ending the drought: new strategies for improving the flow of affordable, effective antivenoms in Asia and Africa.
Williams DJ; Gutiérrez JM; Calvete JJ; Wüster W; Ratanabanangkoon K; Paiva O; Brown NI; Casewell NR; Harrison RA; Rowley PD; O'Shea M; Jensen SD; Winkel KD; Warrell DA
J Proteomics; 2011 Aug; 74(9):1735-67. PubMed ID: 21640209
[TBL] [Abstract][Full Text] [Related]
4. Snake venomics and antivenomics: Proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming.
Gutiérrez JM; Lomonte B; León G; Alape-Girón A; Flores-Díaz M; Sanz L; Angulo Y; Calvete JJ
J Proteomics; 2009 Mar; 72(2):165-82. PubMed ID: 19344652
[TBL] [Abstract][Full Text] [Related]
5. Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa.
Harrison RA; Oluoch GO; Ainsworth S; Alsolaiss J; Bolton F; Arias AS; Gutiérrez JM; Rowley P; Kalya S; Ozwara H; Casewell NR
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005969. PubMed ID: 29045429
[TBL] [Abstract][Full Text] [Related]
6. Reducing the impact of snakebite envenoming in Latin America and the Caribbean: achievements and challenges ahead.
Gutiérrez JM
Trans R Soc Trop Med Hyg; 2014 Sep; 108(9):530-7. PubMed ID: 25096295
[TBL] [Abstract][Full Text] [Related]
7. Snakebite envenoming from a global perspective: Towards an integrated approach.
Gutiérrez JM; Williams D; Fan HW; Warrell DA
Toxicon; 2010 Dec; 56(7):1223-35. PubMed ID: 19951718
[TBL] [Abstract][Full Text] [Related]
8. Pathology-specific experimental antivenoms for haemotoxic snakebite: The impact of immunogen diversity on the in vitro cross-reactivity and in vivo neutralisation of geographically diverse snake venoms.
Alomran N; Alsolaiss J; Albulescu LO; Crittenden E; Harrison RA; Ainsworth S; Casewell NR
PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009659. PubMed ID: 34407084
[TBL] [Abstract][Full Text] [Related]
9. Stability, distribution and use of antivenoms for snakebite envenomation in Latin America: report of a workshop.
Gutiérrez JM; Fan HW; Silvera CL; Angulo Y
Toxicon; 2009 May; 53(6):625-30. PubMed ID: 19673076
[TBL] [Abstract][Full Text] [Related]
10. Development of Equine IgG Antivenoms against Major Snake Groups in Mozambique.
Guidolin FR; Caricati CP; Marcelino JR; da Silva WD
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004325. PubMed ID: 26730709
[TBL] [Abstract][Full Text] [Related]
11. Anti-human erythrocyte antibodies in horse-derived antivenoms used in the treatment of snakebite envenomations.
León G; Rodríguez MA; Rucavado A; Lomonte B; Gutiérrez JM
Biologicals; 2007 Mar; 35(1):5-11. PubMed ID: 16490363
[TBL] [Abstract][Full Text] [Related]
12. Omics meets biology: application to the design and preclinical assessment of antivenoms.
Calvete JJ; Sanz L; Pla D; Lomonte B; Gutiérrez JM
Toxins (Basel); 2014 Dec; 6(12):3388-405. PubMed ID: 25517863
[TBL] [Abstract][Full Text] [Related]
13. Antivenoms for snakebite envenomings.
Gutiérrez JM; León G; Lomonte B; Angulo Y
Inflamm Allergy Drug Targets; 2011 Oct; 10(5):369-80. PubMed ID: 21745181
[TBL] [Abstract][Full Text] [Related]
14. Exploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite Antivenoms.
Alomran N; Blundell P; Alsolaiss J; Crittenden E; Ainsworth S; Dawson CA; Edge RJ; Hall SR; Harrison RA; Wilkinson MC; Menzies SK; Casewell NR
Toxins (Basel); 2022 Jun; 14(7):. PubMed ID: 35878181
[TBL] [Abstract][Full Text] [Related]
15. Preclinical Evaluation of the Efficacy of Antivenoms for Snakebite Envenoming: State-of-the-Art and Challenges Ahead.
Gutiérrez JM; Solano G; Pla D; Herrera M; Segura Á; Vargas M; Villalta M; Sánchez A; Sanz L; Lomonte B; León G; Calvete JJ
Toxins (Basel); 2017 May; 9(5):. PubMed ID: 28505100
[TBL] [Abstract][Full Text] [Related]
16. Antivenom efficacy or effectiveness: the Australian experience.
Isbister GK
Toxicology; 2010 Feb; 268(3):148-54. PubMed ID: 19782716
[TBL] [Abstract][Full Text] [Related]
17. Clinical studies of the effectiveness and safety of antivenoms.
Williams DJ; Habib AG; Warrell DA
Toxicon; 2018 Aug; 150():1-10. PubMed ID: 29746978
[TBL] [Abstract][Full Text] [Related]
18. Antivenom for snakebite envenoming in Sri Lanka: the need for geographically specific antivenom and improved efficacy.
Keyler DE; Gawarammana I; Gutiérrez JM; Sellahewa KH; McWhorter K; Malleappah R
Toxicon; 2013 Jul; 69():90-7. PubMed ID: 23454626
[TBL] [Abstract][Full Text] [Related]
19. The management of snake bite.
Reid HA; Theakston RD
Bull World Health Organ; 1983; 61(6):885-95. PubMed ID: 6609008
[TBL] [Abstract][Full Text] [Related]
20. Experimental manufacture of equine antivenom against yamakagashi (Rhabdophis tigrinus).
Morokuma K; Kobori N; Fukuda T; Uchida T; Sakai A; Toriba M; Ohkuma K; Nakai K; Kurata T; Takahashi M
Jpn J Infect Dis; 2011; 64(5):397-402. PubMed ID: 21937821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
